Abstract:Science Progress, Volume 107, Issue 4, October-December 2024. ObjectiveThis retrospective study aimed to investigate the correlation between neutrophil gelatinase–associated lipocalin (NGAL) levels and the clinical progression and severity of diabetes-related acute kidney injury (AKI). The quantitative determination of NGAL in plasma on the Beckman Coulter AU480 analyzer was measured using the Bioporto NGAL TestTM, a particle-enhanced turbidimetric immunoassay with hospitalized patients at an East Central Georgia Medical Center.MethodsThe clinical determination of plasma NGAL included a retrospective cohort study where 45 adult patients were selectively recruited. The selective criteria were patients with and without diabetes mellitus (DM) at risk for developing AKI admitted to the Medical Center between January and November 2023. All patients included in the study had pNGAL levels measured upon admission and up to 96 h post-admission. Receiver operating characteristics and likelihood ratio methods were used to determine optimal sensitivity, specificity, and cutoff value of pNGAL in AKI patients associated with and without DM.ResultsThe intra-assay and interassay imprecision percent relative standard deviation was between 2.7% and 4.2%. pNGAL levels were higher for patients with AKI compared to non-AKI patients, regardless of DM status. The optimal cutoff value for pNGAL to predict AKI for patients with DM was 293 ng/mL, with a sensitivity of 80% and specificity of 87%. In a multivariate logistic regression model, pNGAL levels at 48 h post-admission were determined to be associated with diabetes-related AKI patients.ConclusionPlasma NGAL levels at 48 h are associated with patients with diabetes-related AKI. The specific cutoff values for AKI for early diagnosis and risk stratification and its association with comorbidities must be determined to improve patient outcomes.

A Highly Sensitive Lateral-Flow Strip Using Latex Microspheres to Detect NGAL in Urine Samples

Development of gold nanoparticle-based lateral-flow strips for NGAL protein detection in urine samples

Detection Strip of Anti-Ngal Antibody Coupled with Fluorescent Microspheres-a Novel Tool for Reliable and Accurate Prediction of Renal Injury

Disposable label-free electrochemical immunosensor based on gold nanoparticles-Prussian blue for neutrophil gelatinase-associated lipocalin detection in urine samples

Development of a europium nanoparticles lateral flow immunoassay for NGAL detection in urine and diagnosis of acute kidney injury

The development of lateral flow devices for urinary biomarkers to assess kidney health

Upconverting Nanoparticle-based Enhanced Luminescence Lateral-Flow Assay for Urinary Biomarker Monitoring

Dual-Signal Electrochemical Biosensor for Neutrophil Gelatinase-Associated Lipocalin Based on MXene-Polyaniline and Cu-MOF/Single-Walled Carbon Nanohorn Nanostructures

Electrochemical detection of acute renal disease biomarker by Galinstan nanoparticles interfaced to bilayer polymeric structured dirhenium heptoxide film

An account on current status of Point-of-Care Lateral Flow Tests for Kidney Biomarker detection

Validation of plasma neutrophil gelatinase–associated lipocalin as a biomarker for diabetes-related acute kidney injury

N-GAL: Diagnosing AKI as soon as possible

Urinary neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury in sepsis patients in the emergency department

Urinary Neutrophil Gelatinase-Associated Lipocalin and L-type Fatty Acid Binding Protein As Diagnostic Markers of Early Acute Kidney Injury after Liver Transplantation

Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C in Early Detection of Pediatric Acute Kidney Injury; a Diagnostic Accuracy Study

Paper-based multiplex colorimetric vertical flow assay with smartphone readout for point-of-care detection of acute kidney injury biomarkers

3: A REVIEW OF NGAL BIOMARKER OR NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN

Urinary neutrophil gelatinase-associated lipocalin, a biomarker for systemic inflammatory response syndrome in patients with nephrolithiasis.

Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis.

Clinical Significance of Serum Neutropbil Gelatinase-Associated Lipocalin Detection in Early Diagnosis of Acute Kidney Injury

Using lipocalin as a prognostic biomarker in acute kidney injury